104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
SB2104
 
Introduced 2/6/2025, by Sen. Sue Rezin
 
SYNOPSIS AS INTRODUCED:

New Act
    Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. Defines terms.


LRB104 03751 SPS 13775 b


 
 
A BILL FOR
 
SB2104LRB104 03751 SPS 13775 b


1    AN ACT concerning regulation.

2    Be it enacted by the People of the State of Illinois, 
3represented in the General Assembly:

4    Section 1. Short title. This Act may be cited as the Sale 
5of Pharmaceuticals on Social Media Act.

6    Section 5. Definition. As used in this Act:
7    "Individual" does not include a manufacturer or 
8distributor identified on the label of a drug approved under 
9the Federal Food, Drug, and Cosmetic Act, a biological product 
10licensed under the Public Health Service Act, or a drug 
11marketed in accordance with an over-the-counter monograph 
12under the Federal Food, Drug, and Cosmetic Act.
13    "Social media" has the same meaning as defined in Section 
146-5 of the Liquor Control Act of 1934.

15    Section 10. Sale of pharmaceuticals on social media; 
16verification process. Notwithstanding any other provision of 
17law, no individual shall sell or advertise the sale of a 
18pharmaceutical on social media unless the individual has 
19completed the following verification process:
20        (1) the individual shall submit an image of both the 
21 front and back of the individual's state-issued 
22 identification card to the social media platform upon or 
 
 
SB2104- 2 -LRB104 03751 SPS 13775 b


1 through which the pharmaceutical is to be sold or 
2 advertised;
3        (2) a disclaimer must be included in any advertisement 
4 for the pharmaceutical on the social media platform that 
5 clearly discloses the name of the individual selling the 
6 pharmaceutical;
7        (3) the individual must be identified on the social 
8 media page upon which the pharmaceutical is being sold or 
9 advertised; and
10        (4) the individual must display a disclaimer on the 
11 individual's main page on the social media platform 
12 stating that the owner or operator sells or advertises the 
13 pharmaceutical on that social media platform.